Pacer Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,224	Closed	-$269K	–	3408
2025 Q1	$269K	Buy	+16,224	New	+$295K	﹤0.01%	1676
2024 Q3	–	Sell	-1,735	Closed	-$28.2K	–	2554
2024 Q2	$28.2K	Sell	1,735 -87	-5%	-$1.4K	﹤0.01%	3359
2024 Q1	$33.7K	Buy	+1,822	New	+$45.1K	﹤0.01%	3325
2021 Q2	–	Sell	-2,882	Closed	-$74K	–	1396
2021 Q1	$74K	Buy	2,882 +298	+12%	+$13.1K	﹤0.01%	1348
2020 Q4	$138K	Buy	2,584 +294	+13%	+$14.6K	﹤0.01%	1300
2020 Q3	$94K	Buy	+2,290	New	+$98.9K	﹤0.01%	1256
2018 Q4	–	Sell	-17,604	Closed	-$365K	–	532
2018 Q3	$365K	Buy	+17,604	New	+$277K	0.01%	920
2018 Q1	–	Sell	-2,932	Closed	-$88K	–	1038
2017 Q4	$88K	Sell	2,932 -14,996	-84%	-$480K	0.01%	968
2017 Q3	$675K	Buy	17,928 +2,618	+17%	+$85.2K	0.06%	496
2017 Q2	$427K	Buy	15,310 +1,636	+12%	+$48.8K	0.04%	699
2017 Q1	$470K	Buy	13,674 +2,480	+22%	+$87.5K	0.06%	513
2016 Q4	$323K	Buy	11,194 +498	+5%	+$13.2K	0.05%	648
2016 Q3	$340K	Buy	+10,696	New	+$363K	0.05%	535